Pleomorphism and drug resistant cancer stem cells are characteristic of aggressive primary meningioma cell lines.

scientific article published on 21 July 2017

Pleomorphism and drug resistant cancer stem cells are characteristic of aggressive primary meningioma cell lines. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1090851360
P356DOI10.1186/S12935-017-0441-7
P932PMC publication ID5521079
P698PubMed publication ID28736504

P50authorSaleh S. BaeesaQ38543685
Hans-Juergen SchultenQ57412722
Deema HusseinQ88585977
P2093author name stringGhazi Damanhouri
Angel Carracedo
Adeel Chaudhary
Adel Abuzenadah
Awatif Jamal
Fahad Alghamdi
Hanadi Qashqari
Ishaq Khan
Jaudah Al-Maghrabi
Mohamad Saka
Mohammed Bangash
Nawal Madkhali
Saleh Al-Karim
Kulvinder Saini
Mohammed AlQahtani
P2860cites workA-kinase-anchoring protein 95 functions as a potential carrier for the nuclear translocation of active caspase 3 through an enzyme-substrate-like associationQ24534958
Nestin as a marker of cancer stem cellsQ26851514
Systems biology of cisplatin resistance: past, present and futureQ26863585
Reelin and Notch1 cooperate in the development of the dentate gyrusQ28250584
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastomaQ29615604
Update on meningiomasQ30461960
Maternal dietary choline deficiency alters angiogenesis in fetal mouse hippocampusQ30495988
Adult medulloblastoma: multiagent chemotherapy with cisplatinum and etoposide: a single institutional experience.Q33396889
Phase I study of temozolomide combined with oral etoposide in children with malignant glial tumorsQ33407691
Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMOQ34324259
DNA methylation in the malignant transformation of meningiomasQ34562612
Isolation and characterization of a population of stem-like progenitor cells from an atypical meningioma.Q34625269
Suppression of cytochrome p450 reductase enhances long-term hematopoietic stem cell repopulation efficiency in miceQ34904803
Molecular biological determinations of meningioma progression and recurrenceQ35145251
Genomic landscape of meningiomas.Q35197844
Completeness and concordancy of WHO grade assignment for brain and central nervous system tumors in the United States, 2004-2011Q35638725
Chemotherapy for malignant gliomas based on histoculture drug response assay : a pilot studyQ35675900
Alternative splicing of CHEK2 and codeletion with NF2 promote chromosomal instability in meningiomaQ35763880
Anterior gradient protein 2 expression in high grade head and neck squamous cell carcinoma correlated with cancer stem cell and epithelial mesenchymal transitionQ35832228
Microarray Expression Data Identify DCC as a Candidate Gene for Early Meningioma ProgressionQ35994740
CD133-positive cells might be responsible for efficient proliferation of human meningioma cellsQ36057307
RNAi-mediated abrogation of cathepsin B and MMP-9 gene expression in a malignant meningioma cell line leads to decreased tumor growth, invasion and angiogenesis.Q36074431
Multi-omics analysis of primary glioblastoma cell lines shows recapitulation of pivotal molecular features of parental tumors.Q36116146
Cancer stem cells and cell size: A causal link?Q36296444
Mechanisms and insights into drug resistance in cancerQ36682301
Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningiomaQ36785144
Nestin in central nervous system cellsQ37057915
Nestin expression in human tumors and tumor cell lines.Q37739407
Emerging roles for the pro-oncogenic anterior gradient-2 in cancer development.Q38040355
Merlin, the NF2 gene productQ38105985
CXC receptor and chemokine expression in human meningioma: SDF1/CXCR4 signaling activates ERK1/2 and stimulates meningioma cell proliferationQ38303390
Epidemiological trends of histopathologically WHO classified CNS tumors in developing countries: systematic reviewQ38339814
Cancer stem cells: a challenging paradigm for designing targeted drug therapiesQ38542817
Malignant progression to anaplastic meningioma: Neuropathology, molecular pathology, and experimental modelsQ38572601
Glioma tissue obtained by modern ultrasonic aspiration with a simple sterile suction trap for primary cell culture and pathological evaluationQ38971990
Aberrant methylation and decreased expression of the TGF-β/Smad target gene FBXO32 in esophageal squamous cell carcinomaQ38998339
Cancer stem cell niche models and contribution by mesenchymal stroma/stem cellsQ39113924
Comparative morphological and immunohistochemical study of human meningioma after intracranial transplantation into nude miceQ39419510
The impact of adjuvant stereotactic radiosurgery on atypical meningioma recurrence following aggressive microsurgical resectionQ39470412
Cellular responses to etoposide: cell death despite cell cycle arrest and repair of DNA damageQ39757799
A comparison of the cell lines used in meningioma researchQ40015055
A genetic strategy to overcome the senescence of primary meningioma cell culturesQ40300855
In vitro culture of various typed meningiomas and characterization of a human malignant meningioma cell line (HKBMM).Q40395029
Pediatric brain tumor cancer stem cells: cell cycle dynamics, DNA repair, and etoposide extrusionQ42160720
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutationsQ42548316
Decoding information in cell shapeQ42773442
A lower-dose, lower-toxicity cisplatin-etoposide regimen for childhood progressive low-grade gliomaQ43164381
The expression of tissue factor correlates with proliferative ability in meningiomaQ44527685
Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomasQ45167839
Isolation of mesenchymal stem-like cells in meningioma specimens.Q45849463
Local chemotherapy with cisplatin-depot for glioblastoma multiforme.Q46457345
Cancer stem cell definitions and terminology: the devil is in the details.Q53140630
CNS cancer: molecular classification of glioma.Q55053318
Chromosomal Constitution of MeningiomasQ59057865
Phenotypic change of human cultured meningioma cellsQ73331753
Identification of CD105 (endoglin)-positive stem-like cells in rhabdoid meningiomaQ84895258
Spectroscopic detection of etoposide binding to chromatin components: the role of histone proteinsQ88132081
P921main subjectneoplastic stem cellsQ1638475
P304page(s)72
P577publication date2017-07-21
P1433published inCancer Cell InternationalQ1829859
P1476titlePleomorphism and drug resistant cancer stem cells are characteristic of aggressive primary meningioma cell lines
P478volume17

Reverse relations

cites work (P2860)
Q64945719Array expression meta-analysis of cancer stem cell genes identifies upregulation of PODXL especially in DCC low expression meningiomas.
Q90800024Association Between CD133, CD44, and Nestin Expression and Prognostic Factors in High-Grade Meningioma
Q54983777In situ characterization of stem cells-like biomarkers in meningiomas.
Q93080668Leveraging the Role of the Metastatic Associated Protein Anterior Gradient Homologue 2 in Unfolded Protein Degradation: A Novel Therapeutic Biomarker for Cancer
Q91386928Malignant Transformation and Spine Metastasis of an Intracranial Grade I Meningioma: In Situ Immunofluorescence Analysis of Cancer Stem Cells Case Report and Literature Review

Search more.